Who
John N. Spencer Jr.
Director
Company insider
Files Form 4 as: Director, GeoVax Labs; Director, ClearPoint Neuro; Director, Firstwave Technologies.
In numbers
- Trades disclosed
- 88
- Buys
- 14
- Sells
- 0
- Bought
- $218K
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 7 Jun 2006
- Last trade
- 17 Jun 2026
- Last filed
- 22 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Jun 2026filed 22 Jun 2026 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,000 at $0.00 | filing |
| 17 Jun 2026filed 22 Jun 2026 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,000 at $0.00 | filing |
| 17 Oct 2025filed 20 Oct 2025 | GOVX GeoVax LabsBiotechnology | SEC FORM 4 Bought | $5,50010,000 at $0.55 | filing |
| 5 Jun 2025filed 6 Jun 2025 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 10 Apr 2025filed 11 Apr 2025 | GOVX GeoVax LabsBiotechnology | SEC FORM 4 Bought | $9,80010,000 at $0.98 | filing |
| 12 Aug 2024filed 14 Aug 2024 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,050 at $0.00 | filing |
| 1 Aug 2023filed 14 Aug 2023 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 7 Dec 2021filed 8 Dec 2021 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 11 Aug 2021filed 11 Aug 2021 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 31 Mar 2021filed 2 Apr 2021 | CLPT ClearPoint NeuroMedical Devices | SEC FORM 4 Code A | $6,243319 at $19.57 | filing |
| 31 Dec 2020filed 4 Jan 2021 | CLPT ClearPoint NeuroMedical Devices | SEC FORM 4 Code A | $3,120208 at $15.00 | filing |
| 30 Sep 2020filed 1 Oct 2020 | CLPT ClearPoint NeuroMedical Devices | SEC FORM 4 Code A | $3,123547 at $5.71 | filing |
| 29 Sep 2020filed 29 Sep 2020 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code P | —21,024 at $0.00 | filing |
| 29 Sep 2020filed 29 Sep 2020 | GOVX GeoVax LabsBiotechnology | SEC FORM 4 Bought | $105K21,024 at $5.00 | filing |
| 30 Jun 2020filed 2 Jul 2020 | CLPT ClearPoint NeuroMedical Devices | SEC FORM 4 Code A | $3,120879 at $3.55 | filing |
| 3 Jun 2020filed 17 Jun 2020 | CLPT ClearPoint Neurooption or derivative · Medical Devices | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 31 Mar 2020filed 2 Apr 2020 | CLPT ClearPoint NeuroMedical Devices | SEC FORM 4 Code A | $3,124875 at $3.57 | filing |
| 31 Dec 2019filed 2 Jan 2020 | CLPT ClearPoint NeuroMedical Devices | SEC FORM 4 Code A | $3,125630 at $4.96 | filing |
| 30 Sep 2019filed 1 Oct 2019 | CLPT ClearPoint NeuroMedical Devices | SEC FORM 4 Code A | $3,435667 at $5.15 | filing |
| 28 Jun 2019filed 1 Jul 2019 | CLPT ClearPoint NeuroMedical Devices | SEC FORM 4 Code A | $3,4391,085 at $3.17 | filing |
News
ClearPoint Neuro to Announce Third Quarter 2026 Results October 28, ...CLPT · pr-inside.com · 14 Oct 2026
0 headlines in the last 90 days name John N. Spencer Jr.; 1 article from the last 14 days about the 2 companies they traded most, at most three about any one of them.